What is the recommended protocol for insulin infusion and fluid administration in the management of diabetic ketoacidosis (DKA) in Australia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Australian Guidelines for DKA Protocol: Insulin Infusion and Fluid Management

For management of diabetic ketoacidosis (DKA) in Australia, initial fluid resuscitation with 0.9% NaCl at 15-20 mL/kg/hour should be administered for 1-2 hours before starting insulin therapy, followed by continuous intravenous insulin at 0.1 U/kg/hour. 1

Diagnostic Criteria

  • DKA diagnosis requires:
    • Hyperglycemia (>250 mg/dL or >14 mmol/L)
    • pH <7.3
    • Bicarbonate <15 mEq/L
    • Presence of ketonemia (preferably measured as β-hydroxybutyrate) 1

Fluid Management Protocol

  1. Initial Resuscitation Phase:

    • Isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour for the first 1-2 hours 1
    • This addresses severe dehydration and hypotension before insulin administration
    • Improves tissue perfusion and renal function
  2. Subsequent Fluid Management:

    • After initial resuscitation, transition to 0.45% saline with 5% glucose when blood glucose falls below 250 mg/dL (14 mmol/L) 1, 2
    • Continue at a rate of approximately 250 mL/hour 2
    • Total fluid replacement typically involves 2-3 L of isotonic saline followed by 2-4 L of glucose-containing hypotonic solution 2

Insulin Therapy Protocol

  1. Initiation:

    • Begin insulin therapy 1-2 hours after starting fluid replacement 1
    • Continuous intravenous insulin infusion at 0.1 U/kg/hour 1, 3
  2. Titration:

    • Target blood glucose reduction of 50-75 mg/dL (2.8-4.2 mmol/L) per hour 1
    • Continue insulin infusion until DKA resolution (even after blood glucose normalizes) 4
    • Add glucose to IV fluids when blood glucose falls to approximately 250 mg/dL (14 mmol/L) 4
  3. Transition to Subcutaneous Insulin:

    • Once DKA resolves (glucose <200 mg/dL, bicarbonate ≥18 mEq/L, pH >7.3), transition to subcutaneous insulin 1
    • Continue IV insulin for 1-2 hours after first subcutaneous dose 1

Electrolyte Management

  1. Potassium:

    • Monitor potassium levels every 2-4 hours 1
    • Begin potassium replacement when levels are <5.5 mEq/L and adequate urine output is established 1
    • Typical replacement: 20-30 mEq potassium in each liter of IV fluid
  2. Phosphate:

    • Consider replacement if serum phosphate <1.0 mg/dL or in patients with cardiac dysfunction, anemia, or respiratory depression 1
  3. Bicarbonate:

    • Not routinely indicated when pH >7.0 1
    • May be considered if pH <6.9 1, 5

Monitoring Protocol

  • Blood glucose: Every 1-2 hours until stable 1
  • Electrolytes, BUN, creatinine: Every 2-4 hours 1
  • Venous pH and anion gap: Every 4-6 hours to evaluate resolution of acidosis 1
  • Continuous monitoring of vital signs and neurological status 1

Resolution Criteria

DKA is considered resolved when:

  • Blood glucose <200 mg/dL (11 mmol/L)
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Normalized anion gap
  • Patient is hemodynamically stable 1

Important Caveats

  • Cerebral Edema Prevention: Avoid too rapid correction of hyperglycemia; maintain glucose reduction at 50-75 mg/dL/hour 1, 5
  • Hypoglycemia Risk: Add glucose to IV fluids when blood glucose falls below 250 mg/dL while continuing insulin to clear ketones 4
  • Hypokalemia Risk: Monitor potassium closely and replace as needed; hypokalemia can worsen with insulin therapy 1
  • Fluid Overload: Be cautious with fluid administration in patients with cardiac or renal impairment 1

This protocol aligns with current guidelines while acknowledging that most patients can be effectively managed outside of ICU settings with proper monitoring and adherence to protocols 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.